Yakup Ergün
@dr_yakupergun
Medical Oncologist / Antalya City Hospital
Exploring Evidence-Based Approaches in Cancer | Equality in Oncology Care
ID:1008888613
13-12-2012 13:59:18
1,2K Tweets
2,3K Followers
321 Following
Dear Colleagues,
TWO WEEKS until #ASCO24 🌐
WE ARE READY
WE ARE OncoAlert 🚨
#OncoAlertAF
Dra. María Natalia Gandur Quiroga 🇦🇷
Alizée Camps - - Maléa 🇫🇷
Marta Perachino 🇮🇹
Kathrin Heinrich 🇩🇪
Biagio Ricciuti, MD PhD 🇺🇸
Deniz Can Guven 🇹🇷
Emre Yekedüz 🇺🇸
Hidehito HORINOUCHI 🇯🇵
Fadi Haddad, MD 🇺🇸
Dr. Iván R. González 🇲🇽…
💫🌟🚨 Countdown Alert: Just two weeks!! to go until #ASCO24 !
🌐 The OncoAlert team is all set to bring the latest in oncology from around the globe!
🇦🇷 Dra. María Natalia Gandur Quiroga
🇫🇷 Alizée Camps - - Maléa
🇮🇹 Marta Perachino
🇩🇪 Kathrin Heinrich
🇺🇸 Biagio Ricciuti, MD PhD
🇹🇷 Deniz Can Guven
🇺🇸 Emre Yekedüz…
📘Targeting KRAS in Colorectal Cancer
JCO Oncology Practice
✅A precision review
➡️KRAS inhibitors for G12C mutants
➡️Allele-specific inhibitors
➡️panKRAS and panRAS inhibitors
➡️Unique biological features of RAS-mutant CRC
✅Novel therapeutic avenues
👉doi.org/10.1200/OP.23.……
💊In oncology, we use steroids for many different indications.
💥A guide on steroid equivalence, dose reduction recommendations, treatment of adrenal insufficiency and more👇
Endocrine Society
academic.oup.com/jcem/advance-a…
KEYNOTE-057 JUST OUT on The Lancet Oncology
Investigates pembrolizumab 🧪efficacy and safety in BCG-unresponsive high-risk non-muscle-invasive #BladderCancer ineligible for or refusing radical cystectomy
✅Revealing in cohort B (papillary tumors without carcinoma in situ) a…
👀Is W&W approach suitable for those with ncCR? Unknowns:What % of ncCRs convert to cCRs? How can we predict these patients? Average time from ncCR to cCR? How long to wait and when to act? JAMA Oncology Yakup Ergün Arndt Vogel OncoDaily Enes Erul MD doi:10.1001/jamaoncol.2024.0856
Association between adjuvant endocrine therapy intake timing and DFS in patients with BC
Does the circadian rhythm affect endocrine therapy metabolism?
💥According to this study, taking tamoxifen in the evening/night is associated with better DFS
OncoAlert eBioMedicine – The Lancet Discovery Science…
Targeting the EGFR signalling pathway in metastatic colorectal cancer
An excellent review👇
The Lancet Gastroenterology & Hepatology
thelancet.com/journals/langa…